FdaApplication

NDA 016721

Back to search

Identifiers

Properties

PropertyValue
applicant_nameVALEANT PHARMACEUTICALS INTERNATIONAL
application_typeNDA

Products (2)

ProductActive ingredientStrengthDosage form
DALMANEFLURAZEPAM HYDROCHLORIDE15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE;ORAL
DALMANEFLURAZEPAM HYDROCHLORIDE30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**CAPSULE;ORAL

2 products